Earlier this year, DTB's founding editor, Andrew Herxheimer, died aged 90 years. Andrew established DTB's reputation for producing succinct, accurate, impartial and independent reviews on the use of drugs and the management of diseases.1 In addition, he recognised the importance of involving patients in making treatment decisions and the need to help patients weigh up the pros and cons of treatments.2,3 Through his work with the Cochrane Collaboration, he raised awareness of the adverse effects of interventions. As prescribing of medicines is …